The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and efficacy of bevacizumab and systemic therapy in metastatic colorectal cancer (mCRC) patients with peritoneal disease in the Treatment of Recurrent and Advanced Colorectal Cancer (TRACC) database.
Aflah Roohullah
No relevant relationships to disclose
Hui-li Wong
Research Funding - Roche
Katrin Marie Sjoquist
No relevant relationships to disclose
Kathryn Maree Field
Research Funding - Roche
Ben Tran
Research Funding - Roche
Jeremy David Shapiro
Research Funding - Roche
Joseph James McKendrick
Research Funding - Roche
Desmond Yip
Research Funding - Roche
Louise M. Nott
Research Funding - Roche
Peter Gibbs
Consultant or Advisory Role - Roche
Research Funding - Roche
Lorraine A. Chantrill
No relevant relationships to disclose